妇科恶性肿瘤多学科诊疗中国专家共识(2022年版)

Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors(2022 edition)

近年来,随着妇科恶性肿瘤综合治疗新策略的不断涌现,以及生殖肿瘤学和遗传肿瘤理念的演进,传统的“单学科诊疗”模式已难于以最优的方案解决患者的诊疗问题。多学科诊疗(multidisciplinary team,MDT)可以使患者获得最科学、最合理的诊疗,有利于改进和完善现有的治疗方式,从而提高医疗效率及质量。基于MDT领域国内外最新研究进展及临床实践经验,中国抗癌协会妇科肿瘤专业委员会组织国内妇科肿瘤及相关领域的专家,针对妇科恶性肿瘤MDT运行流程、监测评估及质量控制,制订了《妇科恶性肿瘤多学科诊疗中国专家共识(2022年版)》,希望通过本共识,提高中国临床工作者对于妇科恶性肿瘤MDT的认识,以指导和规范MDT在妇科恶性肿瘤诊疗中的临床运用。

Recently, new strategies for the integrated treatment of gynecological malignancies have been improved along with the development of reproductive oncology and hereditary tumors concepts. The traditional “single-disciplinary treatment” mode is difficult to optimally solve the diagnosis and treatment problems of patients. The application of multidisciplinary team(MDT) can provide the most scientific and reasonable diagnosis and treatment plan for patients and refine the existing therapies to improve the efficacy and quality of medical treatment. Based on the most recent advances and clinical practice experience in MDT of gynecological malignancies, The Society of Gynecological Cancer of China Anti-Cancer Association organized multidisciplinary experts in gynecologic oncology and related area to formulate “Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors(2022 edition)”, in order to improve the understanding of MDT among Chinese gynecologic oncologists and further standardize the application of MDT in gynecological malignancies.